Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Turmeric Compound Supplementation Reduces Liver Fat in MASLD
July 2025
This 12-month study explored the impact of ethanol-extracted curcumin on liver health, inflammation, and metabolic parameters in individuals with MASLD.
Read more
2 Jun 2025
Extracellular Volume Fraction Predicts Cirrhosis Severity Accurately
This new study highlights the growing role of extracellular volume measurement using spectral CT, which quantifies the proportion of extracellular matrix.
31 May 2025
Weight Loss Alters Liver Fatty Acid Metabolism Pathways
The findings support the concept that excessive lipogenesis, rather than just fat delivery from other sources, is central to MASLD development.
29 May 2025
Pemafibrate Reduces Liver Fat and Heart Disease Risk
A study has revealed that pemafibrate is more effective than omega-3 fatty acid ethyl in reducing fatty liver index.
27 May 2025
Dual Diabetes Drug Regimen Shows Promise for MASLD
Discover a study that suggests that dual therapy could offer a safer and more effective approach to treating MASLD.
25 May 2025
Bariatric Surgery Alters Fibrinogen Profiles in MASLD
A recent study investigated how different naturally occurring fibrinogen variants relate to obesity, MASLD, and liver fibrosis severity.
23 May 2025
AI Model Enhances Liver Cancer Risk Prediction Accuracy
PLAN-B-DF was trained and internally validated on a large cohort of 5,585 patients, and externally validated.
21 May 2025
Causes of Death in Metabolic Dysfunction-Associated Liver Disease
A recent nationwide Swedish cohort study involving over 13,000 patients with MASLD compared mortality rates and causes of death.
19 May 2025
Rising Impact of MASLD on Pregnancy Outcomes
Breastfeeding, known for its metabolic benefits to both parent and infant, is encouraged in those with MASLD.
Loading posts...
« Previous
1
2
3
4
5
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View